What is a medspa GLP-1 program in Phoenix, AZ?
A medspa GLP-1 program is a prescription weight loss service that a medical spa adds to its treatment menu, typically featuring compounded semaglutide or tirzepatide prescribed through telehealth. For medspas in Phoenix, AZ, the program runs under your existing brand: clients complete an online intake, meet with a provider licensed in Arizona by video, and receive medication from an FDA-registered 503A or 503B pharmacy if it is clinically appropriate. Telehealth Grow supplies the provider network, pharmacy connections, consent templates, EMR and subscription billing, so your team does not need to hire a medical director solely for weight loss. The result is a recurring monthly revenue line that pairs naturally with body contouring, skin tightening and wellness treatments you already offer.
Why Phoenix is a strong market for a medspa GLP-1 program
With an estimated 1,665,481 residents (U.S. Census Bureau, 2025), Phoenix is the largest city in Arizona. It anchors the Phoenix–Mesa–Chandler, AZ metropolitan area, a market of about 5,228,938 people.
Phoenix has grown 3.6% since 2020 — about 57,342 new residents — and that steady growth keeps widening the pool of adults looking for convenient weight loss options.
Phoenix is spread out — roughly 3,105 residents per square mile across 518 square miles. When patients face long drives between appointments, a telehealth-first GLP-1 program removes one of the biggest reasons people stop treatment.
Phoenix accounts for about 32% of its metro population, and its +3.6% change since 2020 is slower than Arizona as a whole (+6.6%). As the metro’s anchor, it is where brand awareness spreads fastest — patients from surrounding suburbs already look to Phoenix for health and wellness services.
Your patient base can extend well beyond Phoenix. Within driving distance are Glendale, AZ (6 miles, 261K residents), Scottsdale, AZ (15 miles, 243K residents), Tempe, AZ (15 miles, 191K residents) and Peoria, AZ (20 miles, 201K residents), and telehealth lets one brand serve every one of them.
In Arizona, 29.5% of adults were living with obesity in 2020 CDC Behavioral Risk Factor Surveillance System (BRFSS) data — below the median across U.S. states of 31.3%. Applied to Phoenix’s adult population, that suggests roughly 383,200 adults who could be candidates for a GLP-1 conversation with a licensed provider.
The West has some of the lowest obesity prevalence in CDC data, so brands here win by pairing GLP-1 care with fitness, nutrition and longevity goals rather than selling weight loss alone.
That is the opportunity for medspas and aesthetic practices in Phoenix: a large, recurring need that a branded, compliant medspa GLP-1 program can serve without opening a traditional medical practice.
| Population (2025 est.) | 1,665,481 |
|---|---|
| Change since 2020 Census | +3.6% |
| Metro area | Phoenix–Mesa–Chandler, AZ (5.2M) |
| Population density | 3,105 per sq mi |
| Adult obesity rate (AZ, CDC BRFSS) | 29.5% |
| Estimated adults living with obesity | 383,200 |
| NP practice environment (AANP) | Full practice |
Arizona compliance snapshot for Phoenix
A medspa GLP-1 program serving Phoenix follows Arizona law. Three points matter most:
- Prescriber licensure: every patient located in Phoenix must be treated by a clinician licensed in Arizona.
- Nurse practitioner rules: Arizona is a full practice state in AANP’s classification, which shapes how physician oversight is structured.
- Ownership: the MSO-PC model keeps the business you own separate from the licensed clinical practice.
Read the full Arizona medspa GLP-1 program guide for telehealth prescribing, compounding and advertising rules. Our compliance team verifies current requirements for your business during onboarding; this is general information, not legal advice.
Revenue potential in Phoenix
Here is an illustrative projection. If a medspa GLP-1 program in Phoenix reached just 0.25% of the adults estimated to be living with obesity, and each active patient generated about $120 in monthly profit (the benchmark used in our revenue calculator), the numbers would look like this:
| Adults living with obesity (est.) | 383,200 |
|---|---|
| Active patients at 0.25% reach | 958 |
| Estimated monthly profit | $114,960 |
| Estimated annual run rate | $1,379,520 |
Illustration only, not a guarantee. Actual revenue depends on medication costs, dosages, pricing, telehealth visit fees, marketing spend and patient retention.